Loading
companiesCompany
Stitchpoint Bio
Stitchpoint Bio is an Even One Ventures company outside cancer: antisense oligonucleotide medicines designed for a single rare disease patient's mutation, aiming to cut development from decades to months.
Overview
Stitchpoint Bio designs antisense oligonucleotide medicines matched to one patient's mutation, one sequence for one person, for the N-of-1 rare disease patients that conventional development leaves behind. It is a rare disease company in the Even One Ventures portfolio and does not work on cancer.
Headquarters
United States (head office not published), US
Funding
All startupsStartup
Investors
Type
Stage
Startup
Website
Similar pages
- CompanyRarivive
Shares Even One Ventures and the tags startup, evenone-portfolio, rare-disease, non-oncology.
- CompanyArden Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, non-oncology.
- CompanyIgnitus Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, non-oncology.
- CompanyPerita Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, non-oncology.
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio.
- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio.
- CompanyMinuteman Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio.